Cargando…
The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11
A successful HIV-1 cure strategy may require enhancing HIV-1 latency to silence HIV-1 transcription. Modulators of gene expression show promise as latency-promoting agents in vitro and in vivo. Here, we identify Su(var)3–9, enhancer-of-zeste, and trithorax (SET) and myeloid, Nervy, and DEAF-1 (MYND)...
Autores principales: | Boehm, Daniela, Lam, Victor, Schnolzer, Martina, Ott, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124996/ https://www.ncbi.nlm.nih.gov/pubmed/36897778 http://dx.doi.org/10.1016/j.celrep.2023.112234 |
Ejemplares similares
-
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
por: Talibov, Vladimir O., et al.
Publicado: (2021) -
Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
por: Padilla, Alyssa, et al.
Publicado: (2023) -
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
por: Reynoird, Nicolas, et al.
Publicado: (2016) -
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
por: Li, Linda Xiaoyan, et al.
Publicado: (2018) -
Exploration of the Substrate Preference of Lysine
Methyltransferase SMYD3 by Molecular Dynamics Simulations
por: Sun, Jixue, et al.
Publicado: (2019)